認知障害および認知症の発症に対する2型糖尿病の治療効果
Información
- DOI:
- https://doi.org/10.1002/14651858.CD003804.pub2Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 15 junio 2017see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Demencia y trastornos cognitivos
- Copyright:
-
- Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
AAS: conceived the review, conducted trial selection, participated in completion of the report and writing the final draft.
MCH: conducted trial selection.
RV: coordinated the review process, data extraction, risk of bias assessment, analyses, GRADE assessment, 'Summary of findings' table construction, interpretation of results, participated in completion of the report and writing the final draft.
GM: coordinated the review process, data extraction, risk of bias assessment, analyses, GRADE assessment, 'Summary of findings' table construction, interpretation of results, participated in completion of the report and writing the final draft.
Sources of support
Internal sources
-
No sources of support supplied
External sources
-
NIHR, UK.
This update was supported by the National Institute for Health Research (NIHR), via a Cochrane Programme Grant to the Cochrane Dementia and Cognitive Improvement group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, National Health Service or the Department of Health
Declarations of interest
None known.
Acknowledgements
The authors would like to thank Anna Noel‐Storr, Trials Search Co‐ordinator of the Cochrane Dementia and Cognitive Improvement Group, for her assistance with the design of the search strategy.
Version history
Published | Title | Stage | Authors | Version |
2017 Jun 15 | Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia | Review | Almudena Areosa Sastre, Robin WM Vernooij, Magali González‐Colaço Harmand, Gabriel Martínez | |
2003 Jan 20 | Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia | Review | John Grimley Evans, Almudena Areosa Sastre | |
Differences between protocol and review
-
We have updated the methods in the review since the original review in accordance with current Cochrane and Cochrane Dementia and Cognitive Improvement Group guidelines.
-
We included 'Summary of findings' tables and a methodological assessment of the quality of evidence with the GRADE methodology.
-
We separated blinding of participants and personnel from blinding of outcome assessment.
-
We added two new inclusion criteria: we included only trials that assessed a treatment for Type 2 diabetes that was approved by international guidelines; and we required a minimum intervention duration of 12 weeks.
-
We specified a method for selecting among multiple scales used in a study to measure the same cognitive domain.
-
The authors of the review have changed.